CXCR4 and myocardial infarction: Instead of traditional continuous or multiple-dose treatment at different intervals of time, a single-dose treatment of CXCR4 antagonists at an appropriate time point before reperfusion is suggested to produce a maximal improvement in the cardiac function recovery in MI therapies (e.g., PCI).